<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The glycoconjugates expressed by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells frequently contain sialylated <z:chebi fb="2" ids="50699">oligosaccharide</z:chebi> chains </plain></SENT>
<SENT sid="1" pm="."><plain>Among these <z:chebi fb="2" ids="50699">oligosaccharides</z:chebi> the sialyl Lewis a (sLe(a)) and sialyl Lewis x (sLe(x)) antigens are found to be overexpressed in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> of different origin </plain></SENT>
<SENT sid="2" pm="."><plain>The current study assesses sLe(a) and sLe(x) expression in different colorectal specimens in order to establish the correlation of these biomarkers with both <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of colorectal mucosa and the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Healthy disease-free and inflammatory mucosa specimens showed no presence of the antigens </plain></SENT>
<SENT sid="4" pm="."><plain>sLe(a) was expressed in 6.7% of the healthy tissue from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients, in 20.8% of the <z:mpath ids='MPATH_270'>adenomas</z:mpath>, and in 33.3% and 42.6% of the transitional tissue and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>sLe(x) expression was observed in 6.7% of the healthy tissue from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients, in 27.0% of the <z:mpath ids='MPATH_270'>adenomas</z:mpath>, and in 25.6% and 74.8% of the transitional and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The expression of the sLe(a) and sLe(x) antigens was correlated in <z:mpath ids='MPATH_270'>adenomas</z:mpath>, as well as in healthy and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, the high expression of sLe(x) in <z:mpath ids='MPATH_270'>adenomas</z:mpath> was correlated with a high degree of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (p=0.042) </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, the survival analysis suggested that sLe(a) expression may be a prognostic factor for predicting disease-free survival in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (p=0.012) </plain></SENT>
</text></document>